Advanced Magnetics Reports Positive Phase III Data On Ferumoxytol Iron Replacement Therapy
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm touts faster administration of IV push delivery versus infusion products for chronic kidney disease patients and plans fourth-quarter NDA.